LRRC15 and COVID-19: After we first made our results publicly available as a preprint, two independent research groups subsequently reported very similar results to our own in separate preprints, including identifying LRRC15 as the only novel host protein to be discovered after genome-wide screening, localizing the RBD as the interaction interface, determining that LRRC15 can modulate infection without itself acting as an entry receptor for SARS-CoV-2, and analyses of the expression patterns of LRRC15 in the human body suggesting links to COVID-19 [65,66].